Each additional samosa bites into India’s GDP: Weight problems burden to hit $81.53 bn by 2060
Being obese isn’t merely a private problem—it’s a worldwide financial disaster within the making. Prime Minister Narendra Modi, in his ...
Being obese isn’t merely a private problem—it’s a worldwide financial disaster within the making. Prime Minister Narendra Modi, in his ...
Brace your self for a meals combat in Congress as President-elect Trump presents his well being nominees and lays out ...
By Maggie Fick LONDON (Reuters) -Novo Nordisk on Wednesday trimmed its full-year revenue outlook after reporting weaker-than-expected quarterly gross sales ...
By Tameka Henry Monday, April 8, 2024 | 2 a.m. There are two simultaneous public health crises facing our community: ...
Two experts see major challenges facing the adoption of new obesity drugs.Dr. Kavita Patel, a physician and NBC News medical ...
By Christina Madison Sunday, Oct. 8, 2023 | 2 a.m. Obesity is a serious disease that has become a health ...
© Reuters. FILE PHOTO: Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., ...
Milko Maintaining a Buy Rating for Structure Therapeutics Following the Positive Clinical Data Readout of GSBR-1290 In the fast-evolving world ...
Obesity isn’t simply a matter of how you look or whether you can fit into your favourite jeans. Contrary to ...
jetcityimage While Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) will likely rule the obesity drug market for the next decade, ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.